This website uses cookies to give you the best user experience. If you continue
without changing your settings we'll assume you are happy to receive all RSC cookies.
You can change your cookie settings by navigating to our Privacy and Cookies page and following the instructions. These instructions
are also obtainable from the privacy link at the bottom of any RSC page.
Department of General Biophysics, University of Lodz, 141/143 Pomorska Street, 90-236 Lodz, Poland
E-mail: aklajn@biol.uni.lodz.pl
; Fax: +48 42 635-4474
b
Leibniz Institute of Polymer Research Dresden, Hohe Strasse 6, 01069 Dresden, Germany
E-mail: applhans@ipfdd.de
; Fax: +49 351-465-8565
New J. Chem., 2012,36, 350-353
DOI:
10.1039/C1NJ20444K
Received
26 May 2011,
Accepted
01 Aug 2011
First published online
22 Aug 2011
This article is part of themed collection:
Dendrimers II
Oligosaccharide-modified poly(propylene imine) dendrimers are promising candidates as drug carriers and as anti-prion agents. Here, we report the biodistribution of maltotriose-modified 4th generation poly(propylene imine) (PPI) dendrimers and their ability to cross the blood–brain–barrier that is important if these glycodendrimers are considered as potential therapeutic agents in the central nervous system (CNS).
Fetching data from CrossRef. This may take some time to load.